Mohamad Subandrio
Pelita Anugrah
2 Juni 2016
Epidemiology
• Affects 75 millions in USA, 1 billion worldwide
• Indonesia: 26,5% (Riskesdas 2013)
• Most common, readily identifible, and
reversible risk factor for MI, stroke, heart
failure, AFib, aortic dissection, and PAD
• Causes 2/3 of all strokes,
½ of all cases of IHD
Indonesia Data
• Prevalence: 26,5%
• Diagnosed by a health worker: 9,4%
• Diagnosed by a health worker OR consume
drug(s) to treat hypertension: 9,5%
• Normal blood pressure with hypertension
medication: 0,7%
B. BP stage
C. Home and ambulatory BP monitoring
JNC VII
ETIOLOGY
PRIMARY HT SECONDARY HT
• Primary kidney disease
• Pathogenesis remains • Oral contraceptives
unclear • Drug induced
• Pheocromocytoma
• Angiotensin II &
• Primary aldosteronism
mineralocorticoid activity
• Renovascular disease
• Genetic factors (30%) • Cushing’s syndrome
• Endocrine disorders
(hyperthyroidsm)
• Obstructive sleep apnea
Pathogenesis and
Pathophysiology
Basic Equation of Blood Pressure
Cardiac Peripheral
Blood Pressure = Output
X Resistance
And / Or
Cardiac X Peripheral
Hypertension = Output Resistance
PATHOPHYSIOLOGY
High Salt
Intake Renal Mechanism
Sodium
• Resetting of pressure natriuresis
Retention
• Low birth weight reduces
nephrogenesis
– Decreased total filtration area
Plasma
Volume
– salt dependent hypertension
Blood
Pressure
Diagnosis
History Taking
• Duration and severity
• Assessment of other CV risk factor
• Assessment of target organ damage
• Symptom of identifiable cause of HTN
• Drug/substance that may BP
• Psychosocial and enviromental
• Family history of HTN and CVD
MEASUREMENT TECHNIQUE
• In the office, BP should be measured at least twice
after 5 minutes of rest, with the patient seated in a
chair, the back supported, and the arm bare and at
heart level. Cuff width 80% of the upper arm.